{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:55:00Z","timestamp":1792511700374,"version":"4.5.0"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004605","name":"Zhengzhou University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004605","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.arr.2024.102199","type":"journal-article","created":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T09:41:12Z","timestamp":1705743672000},"page":"102199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Recent trends in treatment strategies for Alzheimer's disease and the challenges: A topical advancement"],"prefix":"10.1016","volume":"94","author":[{"given":"Ni","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2024.102199_bib1","doi-asserted-by":"crossref","first-page":"9677","DOI":"10.1523\/JNEUROSCI.4742-11.2012","article-title":"An effector-reduced anti-beta-amyloid (Abeta) antibody with unique abeta binding properties promotes neuroprotection and glial engulfment of A","volume":"32","author":"Adolfsson","year":"2012","journal-title":"beta. J. Neurosci."},{"key":"10.1016\/j.arr.2024.102199_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2012.01.046","article-title":"Effects of dexpramipexole on brain mitochondrial conductances and cellular bioenergetic efficiency","volume":"1446","author":"Alavian","year":"2012","journal-title":"Brain Res"},{"key":"10.1016\/j.arr.2024.102199_bib3","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1016\/j.jmb.2018.08.010","article-title":"Cysteine-Independent Inhibition of Alzheimer's Disease-like Paired Helical Filament Assembly by Leuco-Methylthioninium (LMT)","volume":"430","author":"Al-Hilaly","year":"2018","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.arr.2024.102199_bib4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neurobiolaging.2020.05.003","article-title":"In vivo positron emission tomography imaging of mitochondrial abnormalities in a mouse model of tauopathy","volume":"94","author":"Barron","year":"2020","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2024.102199_bib5","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1212\/WNL.0b013e3182904faa","article-title":"Safety\/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients","volume":"80","author":"Bartus","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2024.102199_bib6","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(03)00530-1","article-title":"CSF markers for incipient Alzheimer's disease","volume":"2","author":"Blennow","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2024.102199_bib7","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.nrl.2014.02.003","article-title":"Tratamiento de la enfermedad de Alzheimer mediante terapia combinada de af\u00e9resis terap\u00e9utica y hemof\u00e9resis con alb\u00famina e inmunoglobulina intravenosa: fundamentos y aproximaci\u00f3n terap\u00e9utica al estudio AMBAR (Alzheimer Management By Albumin Replacement)","volume":"31","author":"Boada","year":"2016","journal-title":"Neurolog\u00eda"},{"key":"10.1016\/j.arr.2024.102199_bib8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3233\/JAD-2011-110977","article-title":"Gantenerumab: A Novel Human Anti-A\u03b2 Antibody Demonstrates Sustained Cerebral Amyloid-\u03b2 Binding and Elicits Cell-Mediated Removal of Human Amyloid-\u03b2","volume":"28","author":"Bohrmann","year":"2012","journal-title":"J. Alzheimer'S. Dis."},{"key":"10.1016\/j.arr.2024.102199_bib9","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-017-0200-1","article-title":"Absence of CX3CR1 impairs the internalization of Tau by microglia","volume":"12","author":"Bolos","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2024.102199_bib10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00401-019-02013-z","article-title":"Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer's disease","volume":"138","author":"Boza-Serrano","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2024.102199_bib11","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2019.1534","article-title":"Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis","author":"Bridel","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2024.102199_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2018.00330","article-title":"Sleep disorders associated with Alzheimer's disease: a perspective","volume":"12","author":"Brzecka","year":"2018","journal-title":"Front Neurosci."},{"key":"10.1016\/j.arr.2024.102199_bib13","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","article-title":"Synergy between amyloid-\u03b2 and tau in Alzheimer\u2019s disease","volume":"23","author":"Busche","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.arr.2024.102199_bib14","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3109\/00207454.2013.833510","article-title":"Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease","volume":"124","author":"Cai","year":"2014","journal-title":"Int J. Neurosci."},{"key":"10.1016\/j.arr.2024.102199_bib15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.brainres.2019.03.017","article-title":"Dl-3-n-butylphthalide promotes remyelination process in cerebral white matter in rats subjected to ischemic stroke","volume":"1717","author":"Cheng","year":"2019","journal-title":"Brain Res"},{"key":"10.1016\/j.arr.2024.102199_bib16","doi-asserted-by":"crossref","first-page":"703","DOI":"10.15252\/emmm.201606666","article-title":"An intranasally delivered peptide drug ameliorates cognitive decline in Alzheimer transgenic mice","volume":"9","author":"Cheng","year":"2017","journal-title":"EMBO Mol. Med"},{"key":"10.1016\/j.arr.2024.102199_bib17","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/ncb1901","article-title":"Transmission and spreading of tauopathy in transgenic mouse brain","volume":"11","author":"Clavaguera","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.arr.2024.102199_bib18","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.trci.2019.05.008","article-title":"Alzheimer's disease drug development pipeline: 2019","volume":"5","author":"Cummings","year":"2019","journal-title":"Alzheimers Dement (N. Y"},{"key":"10.1016\/j.arr.2024.102199_bib19","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3233\/JAD-180766","article-title":"Treatment Combinations for Alzheimer's Disease: Current and Future Pharmacotherapy Options","volume":"67","author":"Cummings","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2024.102199_bib20","article-title":"Pan-tau antibody BIIB076 exhibits promising safety and biomarker profile in cynomolgus monkey toxicity study","author":"Czerkowicz","year":"2017","journal-title":"Poster Present.: Wednesday"},{"key":"10.1016\/j.arr.2024.102199_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/srep28912","article-title":"Alzheimer's disease Advax(CpG)- adjuvanted MultiTEP-based dual and single vaccines induce high-titer antibodies against various forms of tau and Abeta pathological molecules.","volume":"6","author":"Davtyan","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2024.102199_bib22","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.neuron.2018.10.014","article-title":"Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies","volume":"100","author":"Dejanovic","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2024.102199_bib23","article-title":"Novel therapeutic strategies for Alzheimer's disease: Implications from cell-based therapy and nanotherapy","volume":"24","author":"Derakhshankhah","year":"2020","journal-title":"Nanomedicine"},{"key":"10.1016\/j.arr.2024.102199_bib24","article-title":"Unveiling a novel transient druggable pocket in BACE-1 through molecular simulations: Conformational analysis and binding mode of multisite inhibitors","volume":"12","author":"Di Pietro","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2024.102199_bib25","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1210951","article-title":"A phase 3 trial of semagacestat for treatment of Alzheimer's disease","volume":"369","author":"Doody","year":"2013","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.arr.2024.102199_bib26","doi-asserted-by":"crossref","DOI":"10.1186\/s40035-018-0107-y","article-title":"Alzheimer's disease hypothesis and related therapies","volume":"7","author":"Du","year":"2018","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.arr.2024.102199_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226245","article-title":"Gene delivery of a modified antibody to Abeta reduces progression of murine Alzheimer's disease.","volume":"14","author":"Elmer","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2024.102199_bib28","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3233\/JAD-190484","article-title":"Treatment with scFv-h3D6 Prevented Neuronal Loss and Improved Spatial Memory in Young 3xTg-AD Mice by Reducing the Intracellular Amyloid-beta Burden.","volume":"70","author":"Esquerda-Canals","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2024.102199_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtemb.2021.126779","article-title":"Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: Limitations, and current and future perspectives","volume":"67","author":"Fasae","year":"2021","journal-title":"J. Trace Elem. Med Biol."},{"key":"10.1016\/j.arr.2024.102199_bib30","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ajpath.2013.05.005","article-title":"Pyroglutamate-3 amyloid-beta deposition in the brains of humans, non-human primates, canines, and Alzheimer disease-like transgenic mouse models","volume":"183","author":"Frost","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.arr.2024.102199_bib31","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.molimm.2018.07.019","article-title":"A novel Abeta epitope vaccine based on bacterium-like particle against Alzheimer's disease.","volume":"101","author":"Fu","year":"2018","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.arr.2024.102199_bib32","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3233\/JAD-160514","article-title":"An Oral Abeta Vaccine Using a Recombinant Adeno-Associated Virus Vector in Aged Monkeys: Reduction in Plaque Amyloid and Increase in Abeta Oligomers.","volume":"54","author":"Hara","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2024.102199_bib33","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-017-0181-0","article-title":"Inhibition of O-GlcNAcase leads to elevation of O-GlcNAc tau and reduction of tauopathy and cerebrospinal fluid tau in rTg4510 mice","volume":"12","author":"Hastings","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2024.102199_bib34","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1212\/WNL.0b013e31828726f5","article-title":"Alzheimer disease in the United States (2010-2050) estimated using the 2010 census","volume":"80","author":"Hebert","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2024.102199_bib35","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1517\/14656560903044982","article-title":"Development of semagacestat (LY450139), a functional gamma-secretase inhibitor, for the treatment of Alzheimer's disease","volume":"10","author":"Henley","year":"2009","journal-title":"Expert Opin. Pharm."},{"key":"10.1016\/j.arr.2024.102199_bib36","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1080\/14760584.2018.1500905","article-title":"Recent advancements toward therapeutic vaccines against Alzheimer's disease","volume":"17","author":"Herline","year":"2018","journal-title":"Expert Rev. Vaccin."},{"key":"10.1016\/j.arr.2024.102199_bib37","doi-asserted-by":"crossref","first-page":"13966","DOI":"10.1074\/jbc.M110.186338","article-title":"Sequence-independent control of peptide conformation in liposomal vaccines for targeting protein misfolding diseases","volume":"286","author":"Hickman","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102199_bib38","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/jnc.13230","article-title":"Riluzole rescues glutamate alterations, cognitive deficits, and tau pathology associated with P301L tau expression","volume":"135","author":"Hunsberger","year":"2015","journal-title":"J. Neurochem"},{"key":"10.1016\/j.arr.2024.102199_bib39","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nature20587","article-title":"Gamma frequency entrainment attenuates amyloid load and modifies microglia","volume":"540","author":"Iaccarino","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.arr.2024.102199_bib40","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","article-title":"NLRP3 inflammasome activation drives tau pathology","volume":"575","author":"Ising","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.arr.2024.102199_bib41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12974-020-01820-6","article-title":"The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer\u2019s disease: a longitudinal PET study","volume":"17","author":"Ismail","year":"2020","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.arr.2024.102199_bib42","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-018-0378-7","article-title":"Hepatitis B core VLP-based mis-disordered tau vaccine elicits strong immune response and alleviates cognitive deficits and neuropathology progression in Tau.P301S mouse model of Alzheimer's disease and frontotemporal dementia","volume":"10","author":"Ji","year":"2018","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.arr.2024.102199_bib43","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neuropharm.2016.01.028","article-title":"TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice","volume":"105","author":"Jiang","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.arr.2024.102199_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202207719","article-title":"A Therapeutic Nanovaccine that Generates Anti-Amyloid Antibodies and Amyloid-specific Regulatory T Cells for Alzheimer's Disease","volume":"35","author":"Jung","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.arr.2024.102199_bib45","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-019-0559-z","article-title":"Gantenerumab reduces amyloid-beta plaques in patients with prodromal to moderate Alzheimer's disease: a PET substudy interim analysis.","volume":"11","author":"Klein","year":"2019","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.arr.2024.102199_bib46","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/alzrt278","article-title":"First-in-man tau vaccine targeting structural determinants essential for pathological tau-tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer's disease model","volume":"6","author":"Kontsekova","year":"2014","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.arr.2024.102199_bib47","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/alzrt277","article-title":"Identification of structural determinants on tau protein essential for its pathological function: novel therapeutic target for tau immunotherapy in Alzheimer's disease","volume":"6","author":"Kontsekova","year":"2014","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.arr.2024.102199_bib48","unstructured":"Laboratories, F., 2013, Namzaric (memantine hydrochloride extended-release + donepezil hydrochloride). https:\/\/www.centerwatch.com\/directories\/1067-fda-approved-drugs\/listing\/3865-namzaric-memantine-hydrochloride-extended-release-donepezil-hydrochloride."},{"key":"10.1016\/j.arr.2024.102199_bib49","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-018-0340-8","article-title":"Safety, tolerability and immunogenicity of an active anti-Abeta40 vaccine (ABvac40) in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase I trial","volume":"10","author":"Lacosta","year":"2018","journal-title":"Alzheimers Res Ther."},{"issue":"9","key":"10.1016\/j.arr.2024.102199_bib50","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/npp.2013.70","article-title":"Blockade of Tau Hyperphosphorylation and Ab1 \u2013 42 Generation by the Aminotetrahydrofuran Derivative ANAVEX2-73, a Mixed Muscarinic and r1 Receptor Agonist, in a Nontransgenic Mouse Model of Alzheimer \u2019 s Disease","author":"Lahmy","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.arr.2024.102199_bib51","doi-asserted-by":"crossref","first-page":"S427","DOI":"10.3233\/JAD-179923","article-title":"Targeting Insulin for Alzheimer's Disease: Mechanisms, Status and Potential Directions","volume":"64","author":"Lee","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2024.102199_bib52","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.celrep.2016.06.099","article-title":"Antibody-Mediated Targeting of Tau In Vivo Does Not Require Effector Function and Microglial Engagement","volume":"16","author":"Lee","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.arr.2024.102199_bib53","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.trci.2016.06.004","article-title":"NPT088 reduces both amyloid-beta and tau pathologies in transgenic mice.","volume":"2","author":"Levenson","year":"2016","journal-title":"Alzheimers Dement (N. Y"},{"key":"10.1016\/j.arr.2024.102199_bib54","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jalz.2019.07.002","article-title":"Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota","volume":"15","author":"Li","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2024.102199_bib55","first-page":"240","article-title":"CERE-110, an adeno-associated virus-based gene delivery vector expressing human nerve growth factor for the treatment of Alzheimer's disease","volume":"12","author":"Mandel","year":"2010","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.arr.2024.102199_bib56","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.cell.2019.02.014","article-title":"Multi-sensory Gamma Stimulation Ameliorates Alzheimer's-Associated Pathology and Improves Cognition","volume":"177","author":"Martorell","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.arr.2024.102199_bib57","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1021\/acschemneuro.7b00457","article-title":"Crafting of Neuroprotective Octapeptide from Taxol-Binding Pocket of beta-Tubulin","volume":"9","author":"Mondal","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2024.102199_bib58","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809316","article-title":"The BACE-1 inhibitor CNP520 for prevention trials in Alzheimer's disease","volume":"10","author":"Neumann","year":"2018","journal-title":"EMBO Mol. Med"},{"key":"10.1016\/j.arr.2024.102199_bib59","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809316","article-title":"The BACE-1 inhibitor CNP520 for prevention trials in Alzheimer's disease","volume":"10","author":"Neumann","year":"2018","journal-title":"EMBO Mol. Med"},{"key":"10.1016\/j.arr.2024.102199_bib60","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/brain\/awx052","article-title":"Combined effects of scanning ultrasound and a tau-specific single chain antibody in a tau transgenic mouse model","volume":"140","author":"Nisbet","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.arr.2024.102199_bib61","first-page":"10","article-title":"FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer\u2019s disease","author":"Novak","year":"2018","journal-title":"Alzheimer'S. Res. Ther."},{"key":"10.1016\/j.arr.2024.102199_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/5380346","article-title":"Clinical Trials in Alzheimer\u2019s Disease: A Hurdle in the Path of Remedy","volume":"2020","author":"Oxford","year":"2020","journal-title":"Int. J. Alzheimer'S. Dis."},{"key":"10.1016\/j.arr.2024.102199_bib63","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1111\/bph.14585","article-title":"Mitochondrial dysfunction in Alzheimer's disease: Role in pathogenesis and novel therapeutic opportunities","volume":"176","author":"Perez","year":"2019","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.arr.2024.102199_bib64","unstructured":"Petr Novak, R.S.E.K., Stanislav Katina, L.F.M.P., Matej Ondrus, S.R.M.S., 2017, Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer \u2019 s disease: a randomised, double-blind, placebo-controlled, phase 1 trial."},{"key":"10.1016\/j.arr.2024.102199_bib65","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/nutrit\/nuw023","article-title":"Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease","volume":"74","author":"Pistollato","year":"2016","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.arr.2024.102199_bib66","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17313-1","article-title":"Prophylactic Active Tau Immunization Leads to Sustained Reduction in Both Tau and Amyloid-beta Pathologies in 3xTg Mice.","volume":"7","author":"Rajamohamedsait","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2024.102199_bib67","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1750-1326-8-20","article-title":"Fluid biomarkers in Alzheimer's disease - current concepts","volume":"8","author":"Rosen","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2024.102199_bib68","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-018-0441-4","article-title":"Active full-length DNA Abeta42 immunization in 3xTg-AD mice reduces not only amyloid deposition but also tau pathology.","volume":"10","author":"Rosenberg","year":"2018","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.arr.2024.102199_bib69","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1172\/JCI133737","article-title":"Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease","volume":"130","author":"Roy","year":"2020","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.arr.2024.102199_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23051068","article-title":"Passive Abeta Immunotherapy: Current Achievements and Future Perspectives.","volume":"23","author":"Schilling","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.arr.2024.102199_bib71","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces Abeta plaques in Alzheimer's disease.","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.arr.2024.102199_bib72","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3233\/JAD-189010","article-title":"Tau Immunotherapies for Alzheimer's Disease and Related Tauopathies: Progress and Potential Pitfalls","volume":"66","author":"Sigurdsson","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2024.102199_bib73","doi-asserted-by":"crossref","first-page":"14771","DOI":"10.1073\/pnas.1302212110","article-title":"Low levels of copper disrupt brain amyloid-beta homeostasis by altering its production and clearance.","volume":"110","author":"Singh","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.arr.2024.102199_bib74","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2024.102199_bib75","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3233\/JAD-131034","article-title":"Alzheimer's disease-like pathology in senescence-accelerated OXYS rats can be partially retarded with mitochondria-targeted antioxidant SkQ1","volume":"38","author":"Stefanova","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2024.102199_bib76","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.18632\/aging.101054","article-title":"An antioxidant specifically targeting mitochondria delays progression of Alzheimer's disease-like pathology","volume":"8","author":"Stefanova","year":"2016","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.arr.2024.102199_bib77","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.autrev.2008.03.007","article-title":"Natural human antibodies to amyloid beta peptide","volume":"7","author":"Szabo","year":"2008","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.arr.2024.102199_bib78","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-020-0172-y","article-title":"Nasal vaccine delivery attenuates brain pathology and cognitive impairment in tauopathy model mice","volume":"5","author":"Takeuchi","year":"2020","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.arr.2024.102199_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072301","article-title":"Efficacy and safety of a liposome-based vaccine against protein Tau, assessed in tau.P301L mice that model tauopathy","volume":"8","author":"Theunis","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2024.102199_bib80","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3233\/JAD-160695","article-title":"Novel Phospho-Tau Monoclonal Antibody Generated Using a Liposomal Vaccine, with Enhanced Recognition of a Conformational Tauopathy Epitope","volume":"56","author":"Theunis","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2024.102199_bib81","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3233\/JAD-140741","article-title":"The murine version of BAN2401 (mAb158) selectively reduces amyloid-beta protofibrils in brain and cerebrospinal fluid of tg-ArcSwe mice","volume":"43","author":"Tucker","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2024.102199_bib82","doi-asserted-by":"crossref","first-page":"698","DOI":"10.4103\/1673-5374.156953","article-title":"The therapeutic potential of mesenchymal stem cells in Alzheimer's disease: converging mechanisms.","volume":"10","author":"Turgeman","year":"2015","journal-title":"Neural Regen. Res"},{"key":"10.1016\/j.arr.2024.102199_bib83","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s12149-018-1292-6","article-title":"SPECT and PET imaging in Alzheimer\u2019s disease","volume":"32","author":"Valotassiou","year":"2018","journal-title":"Ann. Nucl. Med."},{"key":"10.1016\/j.arr.2024.102199_bib84","doi-asserted-by":"crossref","first-page":"841","DOI":"10.2119\/molmed.2016.00218","article-title":"A modification-specific peptide-based immunization approach using CRM197 carrier protein: Development of a selective vaccine against pyroglutamate Abeta peptides","volume":"22","author":"Vingtdeux","year":"2017","journal-title":"Mol. Med"},{"key":"10.1016\/j.arr.2024.102199_bib85","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.trci.2017.03.005","article-title":"UB-311, a novel UBITh((R)) amyloid beta peptide vaccine for mild Alzheimer's disease","volume":"3","author":"Wang","year":"2017","journal-title":"Alzheimers Dement (N. Y)"},{"key":"10.1016\/j.arr.2024.102199_bib86","doi-asserted-by":"crossref","first-page":"519","DOI":"10.4103\/1673-5374.266061","article-title":"Early active immunization with Abeta3-10-KLH vaccine reduces tau phosphorylation in the hippocampus and protects cognition of mice","volume":"15","author":"Wang","year":"2020","journal-title":"Neural Regen. Res"},{"key":"10.1016\/j.arr.2024.102199_bib87","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41422-019-0216-x","article-title":"Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression","volume":"29","author":"Wang","year":"2019","journal-title":"Cell Res"},{"key":"10.1016\/j.arr.2024.102199_bib88","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(14)70117-6","article-title":"The role of iron in brain ageing and neurodegenerative disorders","volume":"13","author":"Ward","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2024.102199_bib89","doi-asserted-by":"crossref","first-page":"9323","DOI":"10.1523\/JNEUROSCI.0293-11.2011","article-title":"The second-generation active Abeta immunotherapy CAD106 reduces amyloid accumulation in APP transgenic mice while minimizing potential side effects","volume":"31","author":"Wiessner","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2024.102199_bib90","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3233\/JAD-170560","article-title":"Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer\u2019s Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial","volume":"61","author":"Wilcock","year":"2017","journal-title":"J. Alzheimer'S. Dis."},{"key":"10.1016\/j.arr.2024.102199_bib91","doi-asserted-by":"crossref","first-page":"849","DOI":"10.2174\/1568026615666150827095102","article-title":"Relationships between mitochondria and neuroinflammation: implications for Alzheimer's disease","volume":"16","author":"Wilkins","year":"2016","journal-title":"Curr. Top. Med Chem."},{"key":"10.1016\/j.arr.2024.102199_bib92","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1474-4422(12)70140-0","article-title":"Safety, tolerability, and antibody response of active A\u03b2 immunotherapy with CAD106 in patients with Alzheimer\u2019 s disease: randomised, double-blind, placebo-controlled, first-in-human study","volume":"11","author":"Winblad","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2024.102199_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113240","article-title":"Toll-like receptor 4 and CD11b expressed on microglia coordinate eradication of Candida albicans cerebral mycosis","volume":"42","author":"Wu","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.arr.2024.102199_bib94","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.neurobiolaging.2012.07.003","article-title":"Zinc induces protein phosphatase 2A inactivation and tau hyperphosphorylation through Src dependent PP2A (tyrosine 307) phosphorylation","volume":"34","author":"Xiong","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2024.102199_bib95","article-title":"Structural basis of gamma-secretase inhibition and modulation by small molecule drugs","author":"Yang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.arr.2024.102199_bib96","doi-asserted-by":"crossref","DOI":"10.1177\/1179573520907397","article-title":"Current and future treatments in Alzheimer disease: an update","volume":"12","author":"Yiannopoulou","year":"2020","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"10.1016\/j.arr.2024.102199_bib97","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nchembio.797","article-title":"Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation","volume":"8","author":"Yuzwa","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.arr.2024.102199_bib98","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.nbd.2008.05.013","article-title":"Tau hyperphosphorylation correlates with reduced methylation of protein phosphatase 2A","volume":"31","author":"Zhou","year":"2008","journal-title":"Neurobiol. Dis."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163724000175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163724000175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T19:18:19Z","timestamp":1761592699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163724000175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":98,"alternative-id":["S1568163724000175"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2024.102199","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent trends in treatment strategies for Alzheimer's disease and the challenges: A topical advancement","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2024.102199","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102199"}}